Will the rising cases of JN.1 COVID variant be a concern for India?

JN.1 mutations provide the subvariant immune-evading capabilities. This has also raised concerns about the efficacy of vaccines against the variant. Early studies indicate that the vaccines work against the variant but they aren’t producing enough antibodies against JN.1. ETHealthworld interacted with a few experts to gain their opinion on the Omicron sub-variant and if JN.1 is responsible for the uptick in cases in India.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/C8he3kR
via